These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


570 related items for PubMed ID: 19010194

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV.
    Bennett MT, Johns KW, Bondy GP.
    Lipids Health Dis; 2007 Jun 13; 6():15. PubMed ID: 17565701
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1495-501. PubMed ID: 19026303
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.
    Wierzbicki AS, Doherty E, Lumb PJ, Chik G, Crook MA.
    Curr Med Res Opin; 2005 Mar 01; 21(3):333-8. PubMed ID: 15811200
    [Abstract] [Full Text] [Related]

  • 27. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 15; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM, Farmer JA.
    Nat Clin Pract Cardiovasc Med; 2006 Dec 15; 3(12):664-72. PubMed ID: 17122799
    [Abstract] [Full Text] [Related]

  • 32. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.
    Patel AR, Ambrose MS, Duffy GA, Cote H, DeNofrio D.
    J Heart Lung Transplant; 2007 Mar 15; 26(3):281-4. PubMed ID: 17346631
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 15; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 35. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E, Davidson MH.
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr 15; 16(2):183-8. PubMed ID: 19262375
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D.
    Am J Cardiol; 2007 Jun 15; 99(12):1706-1713. PubMed ID: 17560879
    [Abstract] [Full Text] [Related]

  • 38. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I, Efthimiadis A, Pappas S, Alexopoulos D, Vlasserou F, Mikhailidis DP.
    Curr Med Res Opin; 2009 Oct 15; 25(10):2571-6. PubMed ID: 19739939
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.
    Am J Cardiol; 2009 Feb 01; 103(3):369-74. PubMed ID: 19166691
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.